Evaluation and Management of Secondary Amenorrhea

Introduction to Hormonal Assessment

The American College of Obstetricians and Gynecologists recommends performing hormonal assessment, including serum FSH, LH, prolactin, and TSH levels, to identify the underlying cause of secondary amenorrhea in reproductive-age women 1, 2

The Endocrine Society suggests that endocrine dysfunction accounts for the vast majority of secondary amenorrhea cases in reproductive-age women, and evaluation must focus on identifying this dysfunction 1, 2

The American Association of Clinical Endocrinologists recommends measuring serum prolactin, as hyperprolactinemia accounts for approximately 20% of secondary amenorrhea cases and may indicate a pituitary adenoma requiring MRI evaluation 3, 2
The American Thyroid Association states that thyroid dysfunction is a reversible cause of amenorrhea and must be excluded in all cases by measuring TSH 1, 2
The Society for Reproductive Endocrinology and Infertility recommends measuring FSH and LH to differentiate between primary ovarian insufficiency and hypothalamic-pituitary dysfunction 1, 2
The American College of Obstetricians and Gynecologists suggests that an LH/FSH ratio >2 with normal or elevated LH suggests polycystic ovary syndrome (PCOS), which is one of the most common causes of secondary amenorrhea, particularly in obese patients 4, 1, 2

The Obesity Society states that obesity is a critical risk factor that significantly increases the likelihood of PCOS, which presents with oligomenorrhea or amenorrhea, anovulation, and metabolic dysfunction 4, 1

The American Association of Clinical Endocrinologists recommends measuring testosterone and androstenedione if signs of hyperandrogenism are present, as these support a PCOS diagnosis 4, 2
The Society for Reproductive Endocrinology and Infertility suggests that progesterone level (<5 ng/mL throughout the cycle) can confirm anovulation, though this is often inferred from the clinical presentation and LH/FSH ratio 1

The American College of Radiology recommends ordering pituitary MRI to rule out prolactinoma if prolactin is elevated (>20 μg/L) 4, 2
The American College of Obstetricians and Gynecologists states that delaying imaging when prolactin is elevated can lead to visual field defects requiring urgent intervention 2
The Endocrine Society recommends diagnosing primary ovarian insufficiency and confirming with repeat FSH 4 weeks later (two elevated values required) if FSH is elevated (>40 mIU/mL) 1, 2
The American Society for Reproductive Medicine suggests that patients with primary ovarian insufficiency can maintain unpredictable ovarian function and should not be presumed infertile 1
The American College of Obstetricians and Gynecologists recommends suspecting PCOS and ordering pelvic ultrasound to identify polycystic ovarian morphology if LH/FSH ratio >2 1, 2
The American Thyroid Association states that treating thyroid dysfunction is essential, as it is a reversible cause of amenorrhea 1, 2

The American College of Obstetricians and Gynecologists warns that never assuming amenorrhea is benign without evaluation can lead to prolonged hypoestrogenism, increasing risks of osteoporosis and cardiovascular disease 2
The Endocrine Society recommends assessing endometrial thickness on the existing ultrasound, as thin endometrium (<5 mm) suggests estrogen deficiency, while thick endometrium (>8 mm) suggests chronic anovulation with unopposed estrogen, increasing endometrial cancer risk 1, 2

The National Osteoporosis Foundation suggests that if hormonal testing reveals significant abnormalities or if amenorrhea extends beyond 6 months despite addressing modifiable factors, consider DXA scan for bone mineral density assessment, as prolonged hypoestrogenism increases fracture risk 3, 2

Functional Hypothalamic Amenorrhea (FHA) accounts for 20-35% of secondary amenorrhea cases, resulting from disruption of the hypothalamic-pituitary-gonadal axis due to stress, excessive exercise, or nutritional deficiencies, characterized by low estradiol levels and disrupted LH pulsatility, according to the Human Reproduction Update 5